Meghan Condon, PA
Physician Assistant · Newark, DENPI 1073176855
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,106 and has fallen 95.1% since, to $54 in 2025.
Across 108 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$310
- Biogen$266
- Amgen$176
- AbbVie$164
- Biohaven Pharmaceuticals, Inc.$149
- UCB, Inc.$69
- plus $947 from 30 others
What the payments were for
- Food & beverage$2,081100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 17 | $310 |
| Biogen | 16 | $266 |
| Amgen(2 entities) | 10 | $176 |
| AbbVie | 9 | $164 |
| Biohaven Pharmaceuticals, Inc. | 6 | $149 |
| UCB, Inc. | 3 | $69 |
| CSL Behring | 3 | $63 |
| MDD US Operations, LLC | 3 | $60 |
| EMD Serono, Inc. | 3 | $59 |
| Merz Pharmaceuticals, LLC | 2 | $55 |
| Johnson & Johnson | 2 | $55 |
| Catalyst Pharmaceuticals, Inc. | 3 | $54 |
| Sanofi | 2 | $52 |
| SK Life Science, Inc. | 2 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Grifols USA, LLC | 2 | $36 |
| Kyowa Kirin, Inc. | 2 | $35 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Argenx US, Inc. | 1 | $31 |
| Neurelis, Inc. | 2 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Bristol Myers Squibb | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Acorda Therapeutics, Inc | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Corium, LLC | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Genentech, Inc. | 1 | $14 |
How this compares
$2,081 in reported general payments places this provider in the 85th percentile of 527 physician assistant providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other physician assistant in Newark
- Vi BanhNewark$12K
- Alexandra KrochtaNewark$9K
- Seth CallahanNewark$7K
- Nicole Wotus-SilvestriNewark$7K
- Kalyn MozulayNewark$5K
- Emma Ellman-GrovesNewark$4K
- Katherine PeisochenskeNewark$4K
- Victoria AtchisonNewark$4K
- Shakara SmithNewark$3K
- Aimee FongNewark$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.